nodes	percent_of_prediction	percent_of_DWPC	metapath
Didanosine—SLC29A1—Fluorouracil—skin cancer	0.751	1	CbGbCtD
Didanosine—Musculoskeletal disorder—Vismodegib—skin cancer	0.0149	0.0657	CcSEcCtD
Didanosine—Leukoderma—Imiquimod—skin cancer	0.00657	0.0291	CcSEcCtD
Didanosine—PNP—Sorafenib—Vismodegib—skin cancer	0.00616	0.584	CbGdCrCtD
Didanosine—Blood alkaline phosphatase increased—Vismodegib—skin cancer	0.00443	0.0196	CcSEcCtD
Didanosine—PNP—Paclitaxel—Docetaxel—skin cancer	0.00439	0.416	CbGdCrCtD
Didanosine—Hepatotoxicity—Vemurafenib—skin cancer	0.00424	0.0188	CcSEcCtD
Didanosine—Abdominal pain upper—Vismodegib—skin cancer	0.00352	0.0156	CcSEcCtD
Didanosine—Tingling sensation—Imiquimod—skin cancer	0.00348	0.0154	CcSEcCtD
Didanosine—Inflammation—Imiquimod—skin cancer	0.00288	0.0128	CcSEcCtD
Didanosine—Hepatomegaly—Dactinomycin—skin cancer	0.00262	0.0116	CcSEcCtD
Didanosine—Hepatotoxicity—Dactinomycin—skin cancer	0.0024	0.0106	CcSEcCtD
Didanosine—Myopathy—Temozolomide—skin cancer	0.00239	0.0106	CcSEcCtD
Didanosine—Alopecia—Vismodegib—skin cancer	0.00235	0.0104	CcSEcCtD
Didanosine—Hepatic function abnormal—Imiquimod—skin cancer	0.00232	0.0103	CcSEcCtD
Didanosine—Hepatotoxicity—Temozolomide—skin cancer	0.00217	0.0096	CcSEcCtD
Didanosine—Liver injury—Temozolomide—skin cancer	0.00199	0.00881	CcSEcCtD
Didanosine—Myalgia—Vismodegib—skin cancer	0.00197	0.00874	CcSEcCtD
Didanosine—Arthralgia—Vismodegib—skin cancer	0.00197	0.00874	CcSEcCtD
Didanosine—Tingling sensation—Fluorouracil—skin cancer	0.00192	0.0085	CcSEcCtD
Didanosine—Numbness—Fluorouracil—skin cancer	0.00186	0.00824	CcSEcCtD
Didanosine—PNP—lymphoid tissue—skin cancer	0.0018	0.147	CbGeAlD
Didanosine—Neuropathy peripheral—Vemurafenib—skin cancer	0.0018	0.00795	CcSEcCtD
Didanosine—Sensory loss—Fluorouracil—skin cancer	0.00178	0.00788	CcSEcCtD
Didanosine—PNP—female reproductive system—skin cancer	0.00173	0.142	CbGeAlD
Didanosine—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00172	0.00763	CcSEcCtD
Didanosine—Dyspepsia—Vismodegib—skin cancer	0.00167	0.00737	CcSEcCtD
Didanosine—Decreased appetite—Vismodegib—skin cancer	0.00165	0.00728	CcSEcCtD
Didanosine—Pain—Vismodegib—skin cancer	0.00162	0.00716	CcSEcCtD
Didanosine—Inflammation—Fluorouracil—skin cancer	0.00159	0.00704	CcSEcCtD
Didanosine—Neuropathy—Temozolomide—skin cancer	0.00157	0.00696	CcSEcCtD
Didanosine—Gastrointestinal pain—Vismodegib—skin cancer	0.00155	0.00685	CcSEcCtD
Didanosine—Dry eye—Temozolomide—skin cancer	0.00155	0.00685	CcSEcCtD
Didanosine—Neuropathy peripheral—Imiquimod—skin cancer	0.00153	0.00678	CcSEcCtD
Didanosine—Abdominal pain—Vismodegib—skin cancer	0.0015	0.00662	CcSEcCtD
Didanosine—Hepatic failure—Dactinomycin—skin cancer	0.0015	0.00662	CcSEcCtD
Didanosine—Neuritis—Docetaxel—skin cancer	0.00149	0.0066	CcSEcCtD
Didanosine—Hepatobiliary disease—Imiquimod—skin cancer	0.00148	0.00654	CcSEcCtD
Didanosine—Chills—Vemurafenib—skin cancer	0.00148	0.00654	CcSEcCtD
Didanosine—Alopecia—Vemurafenib—skin cancer	0.00145	0.00644	CcSEcCtD
Didanosine—PNP—head—skin cancer	0.00145	0.118	CbGeAlD
Didanosine—Hepatotoxicity—Docetaxel—skin cancer	0.00144	0.00638	CcSEcCtD
Didanosine—Blood alkaline phosphatase increased—Temozolomide—skin cancer	0.0014	0.00619	CcSEcCtD
Didanosine—Asthenia—Vismodegib—skin cancer	0.00136	0.00601	CcSEcCtD
Didanosine—Hepatic failure—Temozolomide—skin cancer	0.00135	0.00599	CcSEcCtD
Didanosine—Pruritus—Vismodegib—skin cancer	0.00134	0.00593	CcSEcCtD
Didanosine—SLC29A2—female reproductive system—skin cancer	0.0013	0.106	CbGeAlD
Didanosine—Diarrhoea—Vismodegib—skin cancer	0.00129	0.00573	CcSEcCtD
Didanosine—SLC29A1—nipple—skin cancer	0.00129	0.105	CbGeAlD
Didanosine—Chills—Imiquimod—skin cancer	0.00126	0.00557	CcSEcCtD
Didanosine—Alopecia—Imiquimod—skin cancer	0.00124	0.00549	CcSEcCtD
Didanosine—Arthralgia—Vemurafenib—skin cancer	0.00122	0.0054	CcSEcCtD
Didanosine—Myalgia—Vemurafenib—skin cancer	0.00122	0.0054	CcSEcCtD
Didanosine—Vomiting—Vismodegib—skin cancer	0.0012	0.00533	CcSEcCtD
Didanosine—Drug interaction—Docetaxel—skin cancer	0.0012	0.00531	CcSEcCtD
Didanosine—Rash—Vismodegib—skin cancer	0.00119	0.00528	CcSEcCtD
Didanosine—Dermatitis—Vismodegib—skin cancer	0.00119	0.00528	CcSEcCtD
Didanosine—Anaphylactic shock—Vemurafenib—skin cancer	0.00117	0.00518	CcSEcCtD
Didanosine—Infection—Vemurafenib—skin cancer	0.00116	0.00514	CcSEcCtD
Didanosine—Inflammation—Docetaxel—skin cancer	0.00115	0.00508	CcSEcCtD
Didanosine—Nausea—Vismodegib—skin cancer	0.00112	0.00498	CcSEcCtD
Didanosine—Hepatocellular injury—Docetaxel—skin cancer	0.00111	0.00493	CcSEcCtD
Didanosine—Malaise—Imiquimod—skin cancer	0.0011	0.00488	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00107	0.00472	CcSEcCtD
Didanosine—Neuropathy—Docetaxel—skin cancer	0.00105	0.00463	CcSEcCtD
Didanosine—Arthralgia—Imiquimod—skin cancer	0.00104	0.0046	CcSEcCtD
Didanosine—Myalgia—Imiquimod—skin cancer	0.00104	0.0046	CcSEcCtD
Didanosine—Discomfort—Imiquimod—skin cancer	0.00103	0.00455	CcSEcCtD
Didanosine—Dry mouth—Imiquimod—skin cancer	0.00102	0.0045	CcSEcCtD
Didanosine—Decreased appetite—Vemurafenib—skin cancer	0.00102	0.0045	CcSEcCtD
Didanosine—Hypoaesthesia—Bleomycin—skin cancer	0.000992	0.00439	CcSEcCtD
Didanosine—Infection—Imiquimod—skin cancer	0.000991	0.00438	CcSEcCtD
Didanosine—Agranulocytosis—Dactinomycin—skin cancer	0.000967	0.00428	CcSEcCtD
Didanosine—Anorexia—Imiquimod—skin cancer	0.000951	0.00421	CcSEcCtD
Didanosine—Hyperglycaemia—Temozolomide—skin cancer	0.000948	0.0042	CcSEcCtD
Didanosine—Hepatitis—Dactinomycin—skin cancer	0.00093	0.00412	CcSEcCtD
Didanosine—Blood alkaline phosphatase increased—Docetaxel—skin cancer	0.00093	0.00411	CcSEcCtD
Didanosine—Body temperature increased—Vemurafenib—skin cancer	0.000924	0.00409	CcSEcCtD
Didanosine—Neuropathy peripheral—Temozolomide—skin cancer	0.000918	0.00406	CcSEcCtD
Didanosine—SLC29A1—connective tissue—skin cancer	0.000916	0.0748	CbGeAlD
Didanosine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000909	0.00402	CcSEcCtD
Didanosine—Hepatic failure—Docetaxel—skin cancer	0.0009	0.00398	CcSEcCtD
Didanosine—Paraesthesia—Imiquimod—skin cancer	0.000895	0.00396	CcSEcCtD
Didanosine—Chills—Bleomycin—skin cancer	0.000895	0.00396	CcSEcCtD
Didanosine—Hepatobiliary disease—Temozolomide—skin cancer	0.000886	0.00392	CcSEcCtD
Didanosine—Alopecia—Bleomycin—skin cancer	0.000881	0.0039	CcSEcCtD
Didanosine—Dyspepsia—Imiquimod—skin cancer	0.000878	0.00389	CcSEcCtD
Didanosine—Decreased appetite—Imiquimod—skin cancer	0.000867	0.00384	CcSEcCtD
Didanosine—Hypersensitivity—Vemurafenib—skin cancer	0.000861	0.00381	CcSEcCtD
Didanosine—Pain—Imiquimod—skin cancer	0.000853	0.00377	CcSEcCtD
Didanosine—Renal impairment—Docetaxel—skin cancer	0.00085	0.00376	CcSEcCtD
Didanosine—Neuropathy peripheral—Fluorouracil—skin cancer	0.000846	0.00375	CcSEcCtD
Didanosine—Hepatitis—Temozolomide—skin cancer	0.000841	0.00372	CcSEcCtD
Didanosine—Asthenia—Vemurafenib—skin cancer	0.000839	0.00371	CcSEcCtD
Didanosine—Hypoaesthesia—Temozolomide—skin cancer	0.000837	0.0037	CcSEcCtD
Didanosine—Chills—Dactinomycin—skin cancer	0.000834	0.00369	CcSEcCtD
Didanosine—Pruritus—Vemurafenib—skin cancer	0.000827	0.00366	CcSEcCtD
Didanosine—Alopecia—Dactinomycin—skin cancer	0.000822	0.00364	CcSEcCtD
Didanosine—Gastrointestinal pain—Imiquimod—skin cancer	0.000815	0.00361	CcSEcCtD
Didanosine—Agranulocytosis—Fluorouracil—skin cancer	0.000806	0.00357	CcSEcCtD
Didanosine—Anaemia—Bleomycin—skin cancer	0.000802	0.00355	CcSEcCtD
Didanosine—Diarrhoea—Vemurafenib—skin cancer	0.0008	0.00354	CcSEcCtD
Didanosine—Abdominal pain—Imiquimod—skin cancer	0.000788	0.00349	CcSEcCtD
Didanosine—Body temperature increased—Imiquimod—skin cancer	0.000788	0.00349	CcSEcCtD
Didanosine—Malaise—Bleomycin—skin cancer	0.000783	0.00346	CcSEcCtD
Didanosine—Leukopenia—Bleomycin—skin cancer	0.000777	0.00344	CcSEcCtD
Didanosine—Hypoaesthesia—Fluorouracil—skin cancer	0.000771	0.00341	CcSEcCtD
Didanosine—SLC29A2—lymph node—skin cancer	0.000762	0.0622	CbGeAlD
Didanosine—Chills—Temozolomide—skin cancer	0.000755	0.00334	CcSEcCtD
Didanosine—SLC29A1—mammalian vulva—skin cancer	0.000754	0.0616	CbGeAlD
Didanosine—Anaemia—Dactinomycin—skin cancer	0.000748	0.00331	CcSEcCtD
Didanosine—Vomiting—Vemurafenib—skin cancer	0.000743	0.00329	CcSEcCtD
Didanosine—Alopecia—Temozolomide—skin cancer	0.000743	0.00329	CcSEcCtD
Didanosine—Myalgia—Bleomycin—skin cancer	0.000739	0.00327	CcSEcCtD
Didanosine—Abdominal pain upper—Docetaxel—skin cancer	0.000738	0.00327	CcSEcCtD
Didanosine—Rash—Vemurafenib—skin cancer	0.000737	0.00326	CcSEcCtD
Didanosine—Dermatitis—Vemurafenib—skin cancer	0.000737	0.00326	CcSEcCtD
Didanosine—Hypersensitivity—Imiquimod—skin cancer	0.000735	0.00325	CcSEcCtD
Didanosine—Headache—Vemurafenib—skin cancer	0.000733	0.00324	CcSEcCtD
Didanosine—Discomfort—Bleomycin—skin cancer	0.00073	0.00323	CcSEcCtD
Didanosine—Malaise—Dactinomycin—skin cancer	0.00073	0.00323	CcSEcCtD
Didanosine—Leukopenia—Dactinomycin—skin cancer	0.000725	0.00321	CcSEcCtD
Didanosine—Asthenia—Imiquimod—skin cancer	0.000715	0.00317	CcSEcCtD
Didanosine—Anaphylactic shock—Bleomycin—skin cancer	0.000708	0.00314	CcSEcCtD
Didanosine—Pruritus—Imiquimod—skin cancer	0.000706	0.00312	CcSEcCtD
Didanosine—Infection—Bleomycin—skin cancer	0.000704	0.00311	CcSEcCtD
Didanosine—Nausea—Vemurafenib—skin cancer	0.000695	0.00307	CcSEcCtD
Didanosine—Thrombocytopenia—Bleomycin—skin cancer	0.000694	0.00307	CcSEcCtD
Didanosine—Myalgia—Dactinomycin—skin cancer	0.000689	0.00305	CcSEcCtD
Didanosine—Alopecia—Fluorouracil—skin cancer	0.000685	0.00303	CcSEcCtD
Didanosine—Diarrhoea—Imiquimod—skin cancer	0.000682	0.00302	CcSEcCtD
Didanosine—Discomfort—Dactinomycin—skin cancer	0.000681	0.00301	CcSEcCtD
Didanosine—Anaemia—Temozolomide—skin cancer	0.000677	0.003	CcSEcCtD
Didanosine—Anorexia—Bleomycin—skin cancer	0.000675	0.00299	CcSEcCtD
Didanosine—SLC29A1—lymphoid tissue—skin cancer	0.00067	0.0547	CbGeAlD
Didanosine—Malaise—Temozolomide—skin cancer	0.00066	0.00292	CcSEcCtD
Didanosine—Infection—Dactinomycin—skin cancer	0.000656	0.00291	CcSEcCtD
Didanosine—Leukopenia—Temozolomide—skin cancer	0.000655	0.0029	CcSEcCtD
Didanosine—Thrombocytopenia—Dactinomycin—skin cancer	0.000647	0.00286	CcSEcCtD
Didanosine—SLC29A1—female reproductive system—skin cancer	0.000646	0.0528	CbGeAlD
Didanosine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000645	0.00286	CcSEcCtD
Didanosine—Paraesthesia—Bleomycin—skin cancer	0.000636	0.00282	CcSEcCtD
Didanosine—Vomiting—Imiquimod—skin cancer	0.000634	0.00281	CcSEcCtD
Didanosine—Anorexia—Dactinomycin—skin cancer	0.00063	0.00279	CcSEcCtD
Didanosine—Rash—Imiquimod—skin cancer	0.000629	0.00278	CcSEcCtD
Didanosine—Dermatitis—Imiquimod—skin cancer	0.000628	0.00278	CcSEcCtD
Didanosine—Headache—Imiquimod—skin cancer	0.000625	0.00276	CcSEcCtD
Didanosine—Anaemia—Fluorouracil—skin cancer	0.000624	0.00276	CcSEcCtD
Didanosine—Arthralgia—Temozolomide—skin cancer	0.000623	0.00276	CcSEcCtD
Didanosine—Myalgia—Temozolomide—skin cancer	0.000623	0.00276	CcSEcCtD
Didanosine—Discomfort—Temozolomide—skin cancer	0.000616	0.00273	CcSEcCtD
Didanosine—Decreased appetite—Bleomycin—skin cancer	0.000616	0.00273	CcSEcCtD
Didanosine—Neuropathy peripheral—Docetaxel—skin cancer	0.000611	0.0027	CcSEcCtD
Didanosine—Dry mouth—Temozolomide—skin cancer	0.00061	0.0027	CcSEcCtD
Didanosine—Pain—Bleomycin—skin cancer	0.000606	0.00268	CcSEcCtD
Didanosine—Leukopenia—Fluorouracil—skin cancer	0.000604	0.00267	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000602	0.00266	CcSEcCtD
Didanosine—Anaphylactic shock—Temozolomide—skin cancer	0.000598	0.00264	CcSEcCtD
Didanosine—Infection—Temozolomide—skin cancer	0.000594	0.00263	CcSEcCtD
Didanosine—Nausea—Imiquimod—skin cancer	0.000592	0.00262	CcSEcCtD
Didanosine—Hepatobiliary disease—Docetaxel—skin cancer	0.000589	0.00261	CcSEcCtD
Didanosine—Thrombocytopenia—Temozolomide—skin cancer	0.000585	0.00259	CcSEcCtD
Didanosine—Agranulocytosis—Docetaxel—skin cancer	0.000581	0.00257	CcSEcCtD
Didanosine—Myalgia—Fluorouracil—skin cancer	0.000574	0.00254	CcSEcCtD
Didanosine—Decreased appetite—Dactinomycin—skin cancer	0.000574	0.00254	CcSEcCtD
Didanosine—Anorexia—Temozolomide—skin cancer	0.00057	0.00252	CcSEcCtD
Didanosine—Discomfort—Fluorouracil—skin cancer	0.000567	0.00251	CcSEcCtD
Didanosine—Pain—Dactinomycin—skin cancer	0.000565	0.0025	CcSEcCtD
Didanosine—Body temperature increased—Bleomycin—skin cancer	0.00056	0.00248	CcSEcCtD
Didanosine—Hepatitis—Docetaxel—skin cancer	0.000559	0.00248	CcSEcCtD
Didanosine—Hypoaesthesia—Docetaxel—skin cancer	0.000557	0.00246	CcSEcCtD
Didanosine—Anaphylactic shock—Fluorouracil—skin cancer	0.000551	0.00244	CcSEcCtD
Didanosine—Infection—Fluorouracil—skin cancer	0.000547	0.00242	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000544	0.00241	CcSEcCtD
Didanosine—Gastrointestinal pain—Dactinomycin—skin cancer	0.00054	0.00239	CcSEcCtD
Didanosine—SLC29A1—head—skin cancer	0.000539	0.0441	CbGeAlD
Didanosine—Thrombocytopenia—Fluorouracil—skin cancer	0.000539	0.00239	CcSEcCtD
Didanosine—Paraesthesia—Temozolomide—skin cancer	0.000537	0.00237	CcSEcCtD
Didanosine—Dyspepsia—Temozolomide—skin cancer	0.000526	0.00233	CcSEcCtD
Didanosine—Anorexia—Fluorouracil—skin cancer	0.000525	0.00232	CcSEcCtD
Didanosine—Abdominal pain—Dactinomycin—skin cancer	0.000522	0.00231	CcSEcCtD
Didanosine—Body temperature increased—Dactinomycin—skin cancer	0.000522	0.00231	CcSEcCtD
Didanosine—Hypersensitivity—Bleomycin—skin cancer	0.000522	0.00231	CcSEcCtD
Didanosine—Decreased appetite—Temozolomide—skin cancer	0.000519	0.0023	CcSEcCtD
Didanosine—Pain—Temozolomide—skin cancer	0.000511	0.00226	CcSEcCtD
Didanosine—Asthenia—Bleomycin—skin cancer	0.000508	0.00225	CcSEcCtD
Didanosine—Chills—Docetaxel—skin cancer	0.000502	0.00222	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000502	0.00222	CcSEcCtD
Didanosine—Pruritus—Bleomycin—skin cancer	0.000501	0.00222	CcSEcCtD
Didanosine—Paraesthesia—Fluorouracil—skin cancer	0.000494	0.00219	CcSEcCtD
Didanosine—Alopecia—Docetaxel—skin cancer	0.000494	0.00219	CcSEcCtD
Didanosine—Gastrointestinal pain—Temozolomide—skin cancer	0.000489	0.00216	CcSEcCtD
Didanosine—Hypersensitivity—Dactinomycin—skin cancer	0.000487	0.00215	CcSEcCtD
Didanosine—Dyspepsia—Fluorouracil—skin cancer	0.000485	0.00215	CcSEcCtD
Didanosine—Decreased appetite—Fluorouracil—skin cancer	0.000479	0.00212	CcSEcCtD
Didanosine—Asthenia—Dactinomycin—skin cancer	0.000474	0.0021	CcSEcCtD
Didanosine—Body temperature increased—Temozolomide—skin cancer	0.000472	0.00209	CcSEcCtD
Didanosine—Abdominal pain—Temozolomide—skin cancer	0.000472	0.00209	CcSEcCtD
Didanosine—Pain—Fluorouracil—skin cancer	0.000471	0.00208	CcSEcCtD
Didanosine—Diarrhoea—Dactinomycin—skin cancer	0.000452	0.002	CcSEcCtD
Didanosine—Vomiting—Bleomycin—skin cancer	0.00045	0.00199	CcSEcCtD
Didanosine—Anaemia—Docetaxel—skin cancer	0.00045	0.00199	CcSEcCtD
Didanosine—Rash—Bleomycin—skin cancer	0.000447	0.00198	CcSEcCtD
Didanosine—Dermatitis—Bleomycin—skin cancer	0.000446	0.00198	CcSEcCtD
Didanosine—Hypersensitivity—Temozolomide—skin cancer	0.00044	0.00195	CcSEcCtD
Didanosine—Leukopenia—Docetaxel—skin cancer	0.000436	0.00193	CcSEcCtD
Didanosine—Body temperature increased—Fluorouracil—skin cancer	0.000435	0.00193	CcSEcCtD
Didanosine—Asthenia—Temozolomide—skin cancer	0.000429	0.0019	CcSEcCtD
Didanosine—Pruritus—Temozolomide—skin cancer	0.000423	0.00187	CcSEcCtD
Didanosine—Nausea—Bleomycin—skin cancer	0.000421	0.00186	CcSEcCtD
Didanosine—Vomiting—Dactinomycin—skin cancer	0.00042	0.00186	CcSEcCtD
Didanosine—Rash—Dactinomycin—skin cancer	0.000417	0.00184	CcSEcCtD
Didanosine—Arthralgia—Docetaxel—skin cancer	0.000415	0.00183	CcSEcCtD
Didanosine—Myalgia—Docetaxel—skin cancer	0.000415	0.00183	CcSEcCtD
Didanosine—Diarrhoea—Temozolomide—skin cancer	0.000409	0.00181	CcSEcCtD
Didanosine—Hypersensitivity—Fluorouracil—skin cancer	0.000406	0.0018	CcSEcCtD
Didanosine—Dry mouth—Docetaxel—skin cancer	0.000405	0.00179	CcSEcCtD
Didanosine—Anaphylactic shock—Docetaxel—skin cancer	0.000397	0.00176	CcSEcCtD
Didanosine—Infection—Docetaxel—skin cancer	0.000395	0.00175	CcSEcCtD
Didanosine—Nausea—Dactinomycin—skin cancer	0.000392	0.00174	CcSEcCtD
Didanosine—Pruritus—Fluorouracil—skin cancer	0.00039	0.00172	CcSEcCtD
Didanosine—Thrombocytopenia—Docetaxel—skin cancer	0.000389	0.00172	CcSEcCtD
Didanosine—Vomiting—Temozolomide—skin cancer	0.00038	0.00168	CcSEcCtD
Didanosine—Anorexia—Docetaxel—skin cancer	0.000379	0.00168	CcSEcCtD
Didanosine—SLC29A1—lymph node—skin cancer	0.000378	0.0309	CbGeAlD
Didanosine—Rash—Temozolomide—skin cancer	0.000377	0.00167	CcSEcCtD
Didanosine—Diarrhoea—Fluorouracil—skin cancer	0.000377	0.00167	CcSEcCtD
Didanosine—Dermatitis—Temozolomide—skin cancer	0.000376	0.00167	CcSEcCtD
Didanosine—Headache—Temozolomide—skin cancer	0.000374	0.00166	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000362	0.0016	CcSEcCtD
Didanosine—Paraesthesia—Docetaxel—skin cancer	0.000357	0.00158	CcSEcCtD
Didanosine—Nausea—Temozolomide—skin cancer	0.000355	0.00157	CcSEcCtD
Didanosine—Vomiting—Fluorouracil—skin cancer	0.00035	0.00155	CcSEcCtD
Didanosine—Dyspepsia—Docetaxel—skin cancer	0.00035	0.00155	CcSEcCtD
Didanosine—Rash—Fluorouracil—skin cancer	0.000347	0.00154	CcSEcCtD
Didanosine—Dermatitis—Fluorouracil—skin cancer	0.000347	0.00154	CcSEcCtD
Didanosine—Decreased appetite—Docetaxel—skin cancer	0.000345	0.00153	CcSEcCtD
Didanosine—Headache—Fluorouracil—skin cancer	0.000345	0.00153	CcSEcCtD
Didanosine—Pain—Docetaxel—skin cancer	0.00034	0.0015	CcSEcCtD
Didanosine—Nausea—Fluorouracil—skin cancer	0.000327	0.00145	CcSEcCtD
Didanosine—Gastrointestinal pain—Docetaxel—skin cancer	0.000325	0.00144	CcSEcCtD
Didanosine—Body temperature increased—Docetaxel—skin cancer	0.000314	0.00139	CcSEcCtD
Didanosine—Abdominal pain—Docetaxel—skin cancer	0.000314	0.00139	CcSEcCtD
Didanosine—Hypersensitivity—Docetaxel—skin cancer	0.000293	0.0013	CcSEcCtD
Didanosine—Asthenia—Docetaxel—skin cancer	0.000285	0.00126	CcSEcCtD
Didanosine—Pruritus—Docetaxel—skin cancer	0.000281	0.00124	CcSEcCtD
Didanosine—Diarrhoea—Docetaxel—skin cancer	0.000272	0.0012	CcSEcCtD
Didanosine—Vomiting—Docetaxel—skin cancer	0.000253	0.00112	CcSEcCtD
Didanosine—Rash—Docetaxel—skin cancer	0.000251	0.00111	CcSEcCtD
Didanosine—Dermatitis—Docetaxel—skin cancer	0.00025	0.00111	CcSEcCtD
Didanosine—Headache—Docetaxel—skin cancer	0.000249	0.0011	CcSEcCtD
Didanosine—Nausea—Docetaxel—skin cancer	0.000236	0.00104	CcSEcCtD
